Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD/Scid Mouse Model of Acute Leukemia-Reference-Cited by-同舟云学术

Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD/Scid Mouse Model of Acute Leukemia

Published:2013-06 Issue:6 Volume:19 Page:867-875
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Stevanović Sanja,Nijmeijer Bart A.,van Schie Marianke L.J.,Salvatori Daniela C.F.,Maas Saskia,Griffioen Marieke,Falkenburg J.H. Frederik

Funder

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference54 articles.

1. The current status of hematopoietic cell transplantation;Appelbaum;Annu Rev Med,2003

2. T-cell depletion of HLA-identical transplants in leukemia;Marmont;Blood,1991

3. Minimal GVHD following in vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors;Barge;Exp Hematol,2003

4. T cell depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect;Barrett;Bone Marrow Transplant,1998

5. Graft-versus-leukemia effects of transplantation and donor lymphocytes;Kolb;Blood,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease;Science China Life Sciences;2022-09-22

2. Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2021-09-14

3. Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide;Blood Advances;2020-10-27

4. Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR;Blood;2020-09-17

5. T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies;Frontiers in Immunology;2020-02-21